Achieve Life Sciences, INC Schedule 13G passive stakes

Janus Henderson Group Ltd. has updated its beneficial ownership filing for Achieve Life Sciences, Inc., reporting a 5.4% stake.

Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. have reported beneficial ownership of 8.3% of Achieve Life Sciences, Inc. common stock, primarily through managed accounts.

Vivo Opportunity Funds collectively report beneficial ownership of 5.3 million shares, representing 5.0% of Achieve Life Sciences' outstanding common stock, including shares issuable upon warrant exercise.

Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. have disclosed a beneficial ownership of 6,369,252 shares, representing 6.2% of the outstanding common stock of Achieve Life Sciences, Inc.

Paradigm BioCapital Advisors and Dr. Senai Asefaw have reported a 9.2% beneficial ownership stake in Achieve Life Sciences, Inc. following recent equity issuance.

Venrock Healthcare Capital Partners and affiliates have reported a 5.2% beneficial ownership stake in Achieve Life Sciences, Inc. following a recent private placement.

Franklin Resources, Inc. and its affiliate Franklin Advisers, Inc. reported beneficial ownership of 11.5% of Achieve Life Sciences, Inc. common stock, including warrants.

Alyeska Investment Group, L.P. and its affiliates reported a 5.6% beneficial ownership stake in Achieve Life Sciences, Inc., primarily through common stock and warrants.

Contrarian Alpha, Contrarian Achieve SPV, and related entities, along with Parker Quillen, report beneficial ownership of 4.9% of Achieve Life Sciences, Inc. common stock.

Alyeska Investment Group, L.P. and its affiliates reported beneficial ownership of 9.9% of Achieve Life Sciences, Inc.'s common stock as of June 30, 2025.

Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. report a continued 16.0% beneficial ownership stake in Achieve Life Sciences, Inc., including shares from warrant exercise.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 0.6% of Achieve Life Sciences Inc.'s common stock as of June 30, 2025.

Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. have disclosed a beneficial ownership of 12.6% of Achieve Life Sciences, Inc.'s common stock, including shares issuable from warrants.

The Vanguard Group has filed an amended Schedule 13G, disclosing a reduction in its beneficial ownership of Achieve Life Sciences Inc. common stock to 4.95%.